Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Oct. 19, 2022	Jun. 30, 2021	Jun. 30, 2020	Sep. 01, 2025
Subsequent Event [Line Items]
Offering price per share (in dollars per share)		$ 25.00	$ 23.25
Payments of stock issuance costs		$ 17.5	$ 13.5
Public Stock Offering
Subsequent Event [Line Items]
Shares sold in offering (in shares)		11,500,000	11,155,000
Aggregate net proceeds from stock offering		$ 270.1	$ 245.9
Subsequent Event | Public Stock Offering
Subsequent Event [Line Items]
Shares sold in offering (in shares)	13,750,000
Offering price per share (in dollars per share)	$ 20.00
Aggregate net proceeds from stock offering	$ 259.0
Payments of stock issuance costs	$ 16.0
Subsequent Event | Royalty Agreements
Subsequent Event [Line Items]
Royalty maximum	1.8
Subsequent Event | Royalty Agreements | Maximum
Subsequent Event [Line Items]
Royalty maximum	1.9
Subsequent Event | Royalty Agreements | Brensocatib Global Net Sales
Subsequent Event [Line Items]
Royalty percentage				0.75%
Subsequent Event | Royalty Agreements | ARIKAYCE Global Net Sales
Subsequent Event [Line Items]
Royalty percentage	4.00%			4.50%
Subsequent Event | Secured Debt | Term Loan
Subsequent Event [Line Items]
Aggregate principal amount	$ 350.0
Subsequent Event | Secured Debt | Royalty Agreements
Subsequent Event [Line Items]
Aggregate principal amount	$ 150.0
Subsequent Event | Secured Debt | Secured Overnight Financing Rate (SOFR) | Term Loan
Subsequent Event [Line Items]
Interest rate	2.50%
Subsequent Event | Secured Debt | Secured Overnight Financing Rate (SOFR) | Term Loan | Variable Rate Component Two
Subsequent Event [Line Items]
Interest rate	7.75%